Loomis, Sayles & Company’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8
Closed -$1K 996
2022
Q2
$1K Buy
+8
New +$1.54K ﹤0.01% 933
2017
Q3
Sell
-13
Closed -$2K 947
2017
Q2
$2K Buy
+13
New +$2.09K ﹤0.01% 911
2013
Q3
Sell
-137,858
Closed -$9.93K 750
2013
Q2
$9.93K Buy
+137,858
New +$9.12M 0.04% 477

Other funds holding ICUI

Loomis, Sayles & Company's ICUI Position: Q3 2022 in Review

Loomis, Sayles & Company sold out of ICU Medical (ICUI) in Q3 2022, closing a stake of 8 shares — an estimated $1K sold.

Loomis, Sayles & Company first reported a position in ICUI in Q2 2013 and held it in 3 quarters. The position peaked at $9.93K in Q2 2013. 243 funds tracked by Wall St. Rank hold ICUI as of Q3 2022.

  • Loomis, Sayles & Company reported no remaining ICU Medical position as of Q3 2022 after selling out during the quarter.
  • Loomis, Sayles & Company sold 8 ICU Medical shares in Q3 2022, an estimated $1K.
  • Loomis, Sayles & Company first reported a position in ICU Medical in Q2 2013 and held it in 3 quarters.
  • Loomis, Sayles & Company's ICU Medical position peaked at $9.93K in Q2 2013.
  • 243 funds tracked by Wall St. Rank held ICU Medical as of Q3 2022.

Based on Loomis, Sayles & Company's 13F filing for Q3 2022, filed 14 Nov 2022.